US Bancorp’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

US Bancorp’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-343	Closed	–	–	4332
2022 Q2	$0	Buy	343 +288	+524%	+$475	﹤0.01%	4339
2022 Q1	$0	Hold	55	–	–	﹤0.01%	4279
2021 Q4	$0	Hold	55	–	–	﹤0.01%	4285
2021 Q3	$1K	Hold	55	–	–	﹤0.01%	4048
2021 Q2	$1K	Hold	55	–	–	﹤0.01%	3974
2021 Q1	$1K	Hold	55	–	–	﹤0.01%	3859
2020 Q4	$2K	Hold	55	–	–	﹤0.01%	3623
2020 Q3	$2K	Hold	55	–	–	﹤0.01%	3541
2020 Q2	$2K	Buy	+55	New	+$3.71K	﹤0.01%	3555

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

US Bancorp's EVFM Position: Q3 2022 in Review

US Bancorp sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 343 shares.

US Bancorp first reported a position in EVFM in Q2 2020 and held it in 9 quarters. The position peaked at $2K in Q4 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

US Bancorp reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
US Bancorp sold 343 Evofem Biosciences, Inc. Common Stock shares in Q3 2022.
US Bancorp first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
US Bancorp's Evofem Biosciences, Inc. Common Stock position peaked at $2K in Q4 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.